Wells Fargo initiated coverage on Precigen with a new price target
$PGEN
Biotechnology: Pharmaceutical Preparations
Health Care
Wells Fargo initiated coverage of Precigen with a rating of Overweight and set a new price target of $14.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/22/2024 | Neutral → Underweight | JP Morgan | |
| 5/23/2023 | Neutral | JP Morgan | |
| 11/18/2022 | $7.00 | Overweight | Cantor Fitzgerald |